Celcuity Inc.

Celcuity Inc.verified

CELC

Price:

$88.55

Market Cap:

$4.32B

Operating as a clinical-stage biotechnology company, Celcuity Inc. is dedicated to pioneering precision cancer treatments for patients across the United States. At the heart of their approach is the CELsignia diagnostic platform, which examines live tumor cells from patients. This innovative system aims to uncover the precise cellular dysfunction fueling an individual's cancer, thereby guiding the selection of the most appropriate targeted therapeutic intervention. Among its pipeline of drug candidates is Gedatolisib, an agent engineered to selectively inhibit class I PI3K isoforms and mammalian target of rapamycin (mTOR). This therapy is being developed specifically for advanced or metastat...[Read more]

Industry

Biotechnology

IPO Date

2017-09-20

Stock Exchange

NASDAQ

Ticker

CELC

The PE Ratio as of June 2026 (TTM) for Celcuity Inc. (CELC) is -22.71

According to Celcuity Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -22.71. This represents a change of 28.02% compared to the average of -17.74 of the last 4 quarters.

Celcuity Inc. (CELC) Historical PE Ratio (quarterly & annually)

How has CELC PE Ratio performed in the past?

The mean historical PE Ratio of Celcuity Inc. over the last ten years is -15.97. The current -22.71 PE Ratio has changed 14.12% with respect to the historical average. Over the past ten years (40 quarters), CELC's PE Ratio was at its highest in in the September 2023 quarter at -2.75. The PE Ratio was at its lowest in in the September 2018 quarter at -39.18.

Quarterly (TTM)
Annual

Average

-15.97

Median

-12.36

Minimum

-32.47

Maximum

-4.62

Celcuity Inc. (CELC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Celcuity Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 540.71%

Maximum Annual PE Ratio = -4.62

Minimum Annual Increase = -54.46%

Minimum Annual PE Ratio = -32.47

Quarterly (TTM)
Annual
YearPE RatioChange
2025-29.60540.71%
2024-4.62-14.60%
2023-5.411.10%
2022-5.35-10.26%
2021-5.96-39.93%
2020-9.93-32.86%
2019-14.78-54.46%
2018-32.4743.57%
2017-22.61-22.01%
2016-29.00-27.31%

Celcuity Inc. (CELC) Average PE Ratio

How has CELC PE Ratio performed in the past?

The current PE Ratio of Celcuity Inc. (CELC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-13.21

5-year avg

-10.19

10-year avg

-15.97

Celcuity Inc. (CELC) PE Ratio vs. Peers

How is CELC’s PE Ratio compared to its peers?

Celcuity Inc.’s PE Ratio is greater than CG Oncology, Inc. Common stock (-26.96), less than Ascentage Pharma Group International (-8.95), greater than Centessa Pharmaceuticals plc (-24.33), less than Apogee Therapeutics, Inc. (-22.41), less than Xenon Pharmaceuticals Inc. (-11.88), less than Ultragenyx Pharmaceutical Inc. (-4.02), greater than Travere Therapeutics, Inc. (-223.18), greater than Legend Biotech Corporation (-26.49), less than Disc Medicine, Inc. (-10.83), less than Zai Lab Limited (-10.47),

Build a custom stock screener for Celcuity Inc. (CELC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celcuity Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Celcuity Inc. (CELC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Celcuity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Celcuity Inc.'s PE Ratio?

How is the PE Ratio calculated for Celcuity Inc. (CELC)?

What is the highest PE Ratio for Celcuity Inc. (CELC)?

What is the 3-year average PE Ratio for Celcuity Inc. (CELC)?

What is the 5-year average PE Ratio for Celcuity Inc. (CELC)?

How does the current PE Ratio for Celcuity Inc. (CELC) compare to its historical average?